Perrigo Company (NYSE:PRGO) is set to announce third quarter earning results on Wednesday 4th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, PRGO to report 3Q20 income of $ 0.84 per share.
For the full year, analysts anticipate top line of $ 5143.67 million, while looking forward to income of $ 4.06 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 5,128.00 million ~ $ 5,176.00 million, where as bottomline are predicted in a range of $ 3.95 ~ $ 4.15 per share
Click Here For More Historical Outlooks Of Perrigo Company
Previous Quarter Performance
Perrigo Company unveiled income for the second quarter of $ 1.03 per share, from the revenue of $ 1,219.00 million. The quarterly earnings 19.77 percent compared with the same quarter last year. The consensus estimates are income of $ 0.88 per share from $ 1233.95 million in revenue. The bottom line results beat street analysts by $ 0.15 or 17.05 percent, at the same time, top line results fell short of analysts by $ 14.95 million or 1.21 percent.
Stock Performance
Shares of Perrigo Company traded low $ -0.25 or -0.55 percent on Tuesday, reaching $ 45.36 with volume of 847.10 thousand shares. Perrigo Company has traded high as $ 46.65 and has cracked $ 45.00 on the downward trend
According to the previous trading day, closing price of $ 45.36, representing a 14.00 % increase from the 52 week low of $ 40.01 and a 28.58 % decrease over the 52 week high of $ 63.86.
The company has a market capital of $ 6.19 billion and is part of the Healthcare sector and Drug Manufacturers – Specialty & Generic industry.
Recent Analyst recommendations
- On 17th September 2020, maintained by SVB Leerink at Outperform rating, with $ 63.00 target price.
Conference Call
Perrigo Company will be hosting a conference call at 8:00 AM eastern time on 4th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.perrigo.com
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, minerals and dietary supplements, feminine hygiene, diabetes care, scar management, and anti-parasite categories under the Good Sense, Sergeants, Sentry, Zephrex D, PetArmor, and ScarAway brand names.
